US EditionPublished • loading... • Updated
MLTX Investors Have Opportunity to Lead MoonLake Immunotherapeutics Securities Fraud Lawsuit
- Rosen Law Firm reminds buyers of MoonLake Immunotherapeutics stock about the lead plaintiff deadline of December 15, 2025.
- Investors in MoonLake Immunotherapeutics from March 10, 2024, to September 29, 2025, should note the lead plaintiff deadline of December 15, 2025.
- Purchasers of MoonLake shares between March 10, 2024, and September 29, 2025, may receive compensation with no upfront fees.
- To serve as lead plaintiff, an individual must file a motion by December 15, 2025.
Insights by Ground AI
50 Articles
50 Articles
Law Offices of Howard G. Smith Encourages MoonLake Immunotherapeutics (MLTX) Shareholders to Inquire About Securities Fraud Class Action
Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased MoonLake Immunotherapeutics (“MoonLa...
·Crystal River, United States
Read Full ArticleCoverage Details
Total News Sources50
Leaning Left6Leaning Right5Center18Last UpdatedBias Distribution62% Center
Bias Distribution
- 62% of the sources are Center
62% Center
L 21%
C 62%
R 17%
Factuality
To view factuality data please Upgrade to Premium
